Dallas, Texas (PRWEB) June 30, 2013
Consumer health sees positive growth
Consumer health showed positive growth in value terms in 2012 after successful development in 2011. The positive performance in 2012 indicates the successful adaptation of manufacturers and chemists/pharmacies to legislative requirements introduced in 2011. Many product portfolios were revised, and the product quality improved. Manufacturers and pharmacies tried to compensate for the loss of sales of strictly regulated products by promoting and raising the prices of medicines and other products which are not controlled by the government. At the same time, consumers expanded the range of products purchased, looking for high quality at a reasonable price.
Russian pharmaceutical clusters become a driver of development
The consequences of the government’s industry development strategy Pharma 2020 were obvious in 2012. Pharmaceutical clusters were successfully developing in the vicinity of Moscow and St. Petersburg, Yaroslavl and Kaluga regions, and the Stavropol Territory. Federal and regional authorities created favourable conditions for them. The construction of pharmaceutical manufacturing in Yaroslavl was finished in 2012. Also, foreign companies entered into strategic alliances with Russian manufacturers to locate production in Russia.
Get a copy of Russia Consumer Health Market report at http://www.rnrmarketresearch.com/consumer-health-in-russia-market-report.html or Purchase a copy of this report at http://www.rnrmarketresearch.com/contacts/purchase?rname=102618
Claims of recovery fail to convince consumers
Whilst consumer health in Ireland recorded growth in 2012, this was at lower levels than that seen over the review period. Consumers were assured that the worst was over economically, and that a return to growth was in evidence; albeit an export-led recovery. However, consumer sentiment remained low, and concerns relating to the wider European economy prevailed. Consumer spending remained muted as levels of disposable income remained depressed, with the majority of people focused on debt reduction.
Value and efficacy key to sales
In response to this, value for money continued to feature as a key concern for consumers, with efficacy increasing in importance as a factor in the purchasing decision for many. More than ever, no longer in a position to incur the expense of trying out several different products, consumers were driven by a need to obtain the one product which would address their health issues or concerns effectively.
Get a copy of Ireland Consumer Health Market report at http://www.rnrmarketresearch.com/consumer-health-in-ireland-market-report.html or Purchase a copy of this report at http://www.rnrmarketresearch.com/contacts/purchase?rname=79008
Weaker performance of consumer health in Slovenia
Fast growth within consumer health in past years was fuelled by the deepening economic crisis in Slovenia which is driving down consumer purchasing power and influencing consumer behaviour. Consumers have become more prudent with their purchases and many have started to cut all expenditure which they consider unnecessary. Many areas saw volume sales decreasing or stagnating. However, manufacturers significantly increased prices of many of the most popular OTC remedies at the beginning of 2012 – a development which boosted overall consumer health value sales in Slovenia.
Ageing population and rising health awareness are main sales drivers
As the population in Slovenia is getting older, the need for self-medication is increasing. Many new products designed to treat age related problems, such as vitamins and dietary supplements, are being launched on the market. Besides this, the increasing presence of the health and wellness trend in Slovenia is driving many people to lead healthier lifestyles. However, the more hectic pace of life is leading to an increase in stress-related problems and is boosting sales, especially of calming and sleeping products and digestive remedies.
Foreign multinationals lead sales
Consumer health in Slovenia is dominated by foreign companies. The leading player in the area remains Lek Pharmaceuticals, which is owned by Novartis. However, the company is closely followed by the biggest domestic company, Krka. As many consumers perceive international brands as offering better quality and effectiveness, many of the companies present in the area are foreign multinationals. In addition, the stronger financial background of big multinationals is making it possible for them to be very aggressive in terms of advertising their products.
Get a copy of Slovenia Consumer Health Market report at http://www.rnrmarketresearch.com/consumer-health-in-slovenia-market-report.html or Purchase a copy of this report at http://www.rnrmarketresearch.com/contacts/purchase?rname=59908
Browse more reports on Healthcare Market at http://www.rnrmarketresearch.com/reports/life-sciences/healthcare
RnRMarketResearch.com (http://www.rnrmarketresearch.com/) is an online database of market research reports offers in-depth analysis of over 5000 market segments. The library has syndicated reports by leading market research publishers across the globe and also offer customized market research reports for multiple industries.